Mller J, Hemphill A (2016) Drug target identification in protozoan parasites
Scope exclusions include bariatric devices, dietary supplements, wellness apps, and compounded medications, which are outside our remit
doi: 10.1146/annurev.genom.2.1.153 216 MapendanoCKKishinoTMiyazakiKKondoSYoshiuraKiHishikawaYet al
Without expert guidance, patients risk: Excessive muscle loss Metabolic slowdown Nutritional deficiencies Hormonal imbalances Rapid weight regain The best outcomes happen when patients work with a specialist who understands the complexity of metabolic health and can create a precision, individualized plan
This flexibility is particularly valuable for early-stage discovery work, where protocols evolve rapidly and the ability to fine-tune dose ranges is essential
Competition from retatrutide may push that trend further, but Lillys pricing power as the dominant incretin manufacturer is strong